Ka‐To Shum

407 total citations
8 papers, 338 citations indexed

About

Ka‐To Shum is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Ka‐To Shum has authored 8 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Ka‐To Shum's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ka‐To Shum is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ka‐To Shum collaborates with scholars based in United States, Hong Kong and Saudi Arabia. Ka‐To Shum's co-authors include Julian A. Tanner, Jiehua Zhou, John Rossi, John J. Rossi, Bo‐Jian Zheng, Ming‐Liang He, Yongping Lin, Rory M. Watt, Marie C.M. Lin and Jian‐Dong Huang and has published in prestigious journals such as Angewandte Chemie International Edition, Current Pharmaceutical Design and Human Gene Therapy.

In The Last Decade

Ka‐To Shum

8 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ka‐To Shum United States 6 258 48 35 33 24 8 338
Paul A. Salinas United States 8 408 1.6× 89 1.9× 39 1.1× 26 0.8× 14 0.6× 11 609
Wenning Chu United States 11 236 0.9× 17 0.4× 32 0.9× 21 0.6× 28 1.2× 24 284
Hana Petroková Czechia 11 179 0.7× 53 1.1× 24 0.7× 16 0.5× 41 1.7× 25 336
Rabeb Mouna Derbali Canada 9 194 0.8× 89 1.9× 60 1.7× 10 0.3× 15 0.6× 9 389
Claire Beauvineau France 12 245 0.9× 47 1.0× 28 0.8× 30 0.9× 64 2.7× 20 397
Andrew J. Maloney United States 8 219 0.8× 54 1.1× 74 2.1× 13 0.4× 43 1.8× 12 335
Almudena Ponce-Salvatierra Poland 6 506 2.0× 80 1.7× 27 0.8× 42 1.3× 11 0.5× 6 570
E. Sathyajith Kumarasinghe United States 3 555 2.2× 105 2.2× 37 1.1× 18 0.5× 31 1.3× 4 634
Aliakbar Khalili Yazdi Canada 7 126 0.5× 67 1.4× 26 0.7× 9 0.3× 17 0.7× 9 229
Shahrzad Ahangarzadeh Iran 10 206 0.8× 79 1.6× 66 1.9× 12 0.4× 57 2.4× 27 381

Countries citing papers authored by Ka‐To Shum

Since Specialization
Citations

This map shows the geographic impact of Ka‐To Shum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka‐To Shum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka‐To Shum more than expected).

Fields of papers citing papers by Ka‐To Shum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka‐To Shum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka‐To Shum. The network helps show where Ka‐To Shum may publish in the future.

Co-authorship network of co-authors of Ka‐To Shum

This figure shows the co-authorship network connecting the top 25 collaborators of Ka‐To Shum. A scholar is included among the top collaborators of Ka‐To Shum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka‐To Shum. Ka‐To Shum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Shum, Ka‐To & John J. Rossi. (2015). SiRNA Delivery Methods. Methods in molecular biology. 1364. v–vi. 15 indexed citations
2.
Shum, Ka‐To & John J. Rossi. (2014). Noncoding Oligonucleotides: The Belle of the Ball in Gene Therapy. Advances in genetics. 89. 153–177. 4 indexed citations
3.
Mulcahy, Pádraig J., et al.. (2014). Gene Therapy: A Promising Approach to Treating Spinal Muscular Atrophy. Human Gene Therapy. 25(7). 575–586. 13 indexed citations
4.
Shum, Ka‐To, Jiehua Zhou, & John J. Rossi. (2013). Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma. Journal of Cancer Therapy. 4(4). 872–890. 19 indexed citations
5.
Shum, Ka‐To, Jiehua Zhou, & John Rossi. (2013). Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases. Pharmaceuticals. 6(12). 1507–1542. 57 indexed citations
6.
Shum, Ka‐To, et al.. (2012). G-quadruplex DNA Aptamers and their Ligands: Structure, Function and Application. Current Pharmaceutical Design. 18(14). 2014–2026. 142 indexed citations
7.
Yang, Nan, Julian A. Tanner, Bo‐Jian Zheng, et al.. (2007). Bismuth Complexes Inhibit the SARS Coronavirus. Angewandte Chemie International Edition. 46(34). 6464–6468. 86 indexed citations
8.
Yang, Nan, Julian A. Tanner, Bo‐Jian Zheng, et al.. (2007). Bismuth Complexes Inhibit the SARS Coronavirus. Angewandte Chemie. 119(34). 6584–6588. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026